TransThera Sciences (Nanjing), Inc. (HKG:2617)
Hong Kong · Delayed Price · Currency is HKD 9.38
-0.09 (-0.90%)
Sep 11, 2026, 4:08 PM HKT
HKG:2617 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Cash & Equivalents | 425.27 | 415.41 | 569.51 | 496.63 | 983.93 |
Short-Term Investments | 499.95 | 73.98 | 1.4 | 0.55 | 0.42 |
Trading Asset Securities | - | - | 3.03 | 341.54 | - |
Cash & Short-Term Investments | 925.22 | 489.39 | 573.93 | 838.72 | 984.35 |
Cash Growth | 45.13% | -14.73% | -31.57% | -14.79% | - |
Other Receivables | 2.07 | 2.31 | 0.46 | 0.6 | 1.05 |
Receivables | 2.07 | 2.31 | 0.46 | 0.6 | 1.05 |
Inventory | 0.25 | 0.21 | 0.17 | 0.16 | 0.25 |
Other Current Assets | 10.32 | 8.94 | 10.69 | 6.12 | 176.67 |
Total Current Assets | 937.85 | 500.86 | 585.25 | 845.6 | 1,162 |
Property, Plant & Equipment | 27.89 | 24.02 | 28.77 | 31.62 | 14.5 |
Other Intangible Assets | 0.29 | 0.43 | 0.71 | 0.98 | 1 |
Other Long-Term Assets | 21.21 | 20.6 | 14.87 | 8.89 | 11.83 |
Total Assets | 987.24 | 545.91 | 629.6 | 887.09 | 1,190 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Accounts Payable | 90.37 | 104.1 | 81.24 | 78.58 | 72.24 |
Accrued Expenses | 11.95 | 16.34 | 7.55 | 13.61 | 14.69 |
Current Portion of Leases | 2.71 | 1.65 | 3.16 | 3.46 | 2.69 |
Current Income Taxes Payable | 0.04 | 0.01 | 0.04 | 0.09 | 0.1 |
Current Unearned Revenue | - | 6.4 | 6.4 | 6.4 | 6.6 |
Other Current Liabilities | 1.29 | 1.03 | 4.97 | 0.43 | 0.75 |
Total Current Liabilities | 106.36 | 129.53 | 103.36 | 102.56 | 97.06 |
Long-Term Leases | 2.9 | - | 1.21 | 1.35 | - |
Long-Term Unearned Revenue | - | - | - | - | 0.98 |
Total Liabilities | 109.26 | 129.53 | 104.57 | 103.91 | 98.04 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Common Stock | 407.92 | 396.9 | 381.62 | 381.62 | 379.95 |
Additional Paid-In Capital | - | - | - | 1,573 | 1,555 |
Retained Earnings | - | -1,695 | -1,399 | -1,125 | -781.25 |
Comprehensive Income & Other | 470.07 | 1,715 | 1,543 | -47.05 | -62.02 |
Shareholders' Equity | 877.99 | 416.38 | 525.03 | 783.18 | 1,092 |
Total Liabilities & Equity | 987.24 | 545.91 | 629.6 | 887.09 | 1,190 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Total Debt | 5.61 | 1.65 | 4.37 | 4.81 | 2.69 |
Net Cash (Debt) | 919.61 | 487.74 | 569.56 | 833.91 | 981.66 |
Net Cash Growth | 44.95% | -14.37% | -31.70% | -15.05% | - |
Net Cash Per Share | 2.30 | 1.25 | 1.49 | 2.19 | 2.72 |
Filing Date Shares Outstanding | 401.51 | 396.9 | 381.62 | 381.62 | 360.39 |
Total Common Shares Outstanding | 401.51 | 396.9 | 381.62 | 381.62 | 360.39 |
Working Capital | 831.5 | 371.32 | 481.89 | 743.04 | 1,065 |
Book Value Per Share | 2.19 | 1.05 | 1.38 | 2.05 | 3.03 |
Tangible Book Value | 877.7 | 415.95 | 524.32 | 782.2 | 1,091 |
Tangible Book Value Per Share | 2.19 | 1.05 | 1.37 | 2.05 | 3.03 |
Machinery | - | 28.95 | 28.82 | 28.73 | 28.38 |
Construction In Progress | - | 3.54 | 3.52 | 2.9 | - |
Leasehold Improvements | - | 5.68 | 5.68 | 5.68 | 5.67 |